Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Atyr Pharma Inc (NASDAQ: ATYR) closed at $3.41 down -5.01% from its previous closing price of $3.59. In other words, the price has decreased by -$5.01 from its previous closing price. On the day, 1.06 million shares were traded. ATYR stock price reached its highest trading level at $3.65 during the session, while it also had its lowest trading level at $3.38.
Ratios:
For a deeper understanding of Atyr Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.41 and its Current Ratio is at 5.41. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.19.
On October 04, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $17.
On September 05, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $9.Jefferies initiated its Buy rating on September 05, 2024, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 04 ’25 when Broadfoot Jill Marie sold 1,254 shares for $3.78 per share. The transaction valued at 4,740 led to the insider holds 31,763 shares of the business.
DENYES NANCY sold 899 shares of ATYR for $3,398 on Feb 04 ’25. The General Counsel now owns 26,555 shares after completing the transaction at $3.78 per share. On Jul 24 ’24, another insider, SCHIMMEL PAUL, who serves as the Director of the company, bought 52,300 shares for $1.93 each. As a result, the insider paid 101,038 and bolstered with 413,023 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATYR now has a Market Capitalization of 286243584 and an Enterprise Value of 233640608. For the stock, the TTM Price-to-Sale (P/S) ratio is 1244.50 while its Price-to-Book (P/B) ratio in mrq is 3.96. Its current Enterprise Value per Revenue stands at 994.215 whereas that against EBITDA is -3.469.
Stock Price History:
The Beta on a monthly basis for ATYR is 1.00, which has changed by 0.8138298 over the last 52 weeks, in comparison to a change of 0.22894537 over the same period for the S&P500. Over the past 52 weeks, ATYR has reached a high of $4.22, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -3.44%, while the 200-Day Moving Average is calculated to be 38.07%.
Shares Statistics:
For the past three months, ATYR has traded an average of 825.48K shares per day and 831260 over the past ten days. A total of 83.94M shares are outstanding, with a floating share count of 81.94M. Insiders hold about 2.38% of the company’s shares, while institutions hold 65.86% stake in the company. Shares short for ATYR as of 1738281600 were 3816730 with a Short Ratio of 4.62, compared to 1735603200 on 3647026. Therefore, it implies a Short% of Shares Outstanding of 3816730 and a Short% of Float of 5.9799999999999995.
